CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 16, 2022 · PDUFA decision

AMRX PDUFA decision: a negative outcome, -6.0%

On August 16, 2022, Amneal Pharmaceuticals, Inc. reached its PDUFA decision. The result was a negative outcome, and the stock moved -6.0% in the window around the event.

The move

$3.19
1d before
$3.00
Event day
$2.58
1d after
$2.71
5d after

Pre-catalyst setup

+1.0%
30-day run-up
6383%
30-day volatility
0.9×
volume spike